Poulsen, Amanda Holmen
Younis, Samaira
Thuraiaiyah, Janu
Ashina, Messoud
Funding for this research was provided by:
Lundbeckfonden (R310-2018-3711)
Article History
Received: 6 April 2021
Accepted: 9 June 2021
First Online: 19 July 2021
Declarations
:
: Not applicable.
: Not applicable.
: MA is a consultant, speaker or scientific advisor for AbbVie/Allergan, Amgen, Eli Lilly, Lundbeck, Novartis, and Teva, and primary investigator for ongoing AbbVie, Amgen, Eli Lilly and Lundbeck trials. MA has no ownership interest and does not own stocks of any pharmaceutical company. MA serves as associate editor of <i>Cephalalgia</i>, associate editor of the <i>Journal of Headache and Pain</i>. MA is president of the International Headache Society.